Browse evidence-based analysis of health-related claims and assertions
In this big study of Taiwanese adults, 5 out of every 100 people had signs of depression or anxiety — and more women than men reported these symptoms.
Descriptive
The study used people’s own reports of being diagnosed with depression or scoring high on short mental health questionnaires — which might miss cases because people in Taiwan often don’t talk about mental health.
Even though belly fat seems to link more strongly to depression in men than women, the overall pattern is the same for both — meaning the connection isn’t unique to one sex.
Correlational
How fat is shaped and spread around the belly — not just how big it is — is linked to depression and anxiety, even after accounting for other health factors.
In women, a marker of fat around internal organs is linked to depression or anxiety, but not in men — suggesting men and women may have different biological links between belly fat and mood.
People with higher levels of fat-related blood markers (like triglycerides and sugar) are more likely to have depression or anxiety, hinting that metabolic health might be tied to mental health.
If your waist is a large part of your height or wider than your hips, you’re more likely to have depression or anxiety — and this holds true for both men and women in this study.
A new way to measure belly shape — called the conicity index — is the best single sign among all body measurements to predict depression or anxiety in middle-aged Taiwanese men, and still a strong sign in women.
Being overweight or obese by BMI doesn’t reliably predict depression or anxiety in middle-aged Taiwanese men, and only slightly in women — so weight alone isn’t a good sign of mental health risk.
People with more fat around their waist and hips, compared to overall body weight, are more likely to have symptoms of depression or anxiety, especially in middle-aged Taiwanese adults.
This material’s design helps keep useful charged particles apart while getting rid of the useless ones, which lets it turn benzene completely into CO₂ and water without leaving toxic leftovers.
Mechanistic
Computer models show that when light hits this material, electrons move from one part to the other in a specific pattern that helps it work better.
When benzene is broken down by this material, scientists observed specific chemical steps along the way — like phenolate and acetate — showing how it turns into harmless CO₂ and water.
This material uses light very efficiently — for every photon of UV light it gets, it breaks down a small but measurable number of benzene molecules per gram of material.
Quantitative
A special type of material made by combining two chemicals can break down dangerous benzene gas in the air when exposed to UV light, removing it at a measurable rate.
The drug didn’t make muscles stronger or change how much energy they used during exercise — only how fast they recovered afterward, which points to mitochondria being the target.
Instead of giving growth hormone directly, this drug tricks the body into making its own in a natural rhythm, which might be safer for blood sugar.
We know muscle energy recovery got better, but we don’t know if it’s because there are more mitochondria, bigger ones, or just ones that work better.
Because so few people finished the study and the muscle energy didn’t improve much more in the drug group than the placebo group, we can’t say for sure the drug caused the improvement.
In people who took the placebo, IGF-I didn’t go up much, and their muscle energy recovery didn’t link to IGF-I — meaning the connection only showed up when the drug raised IGF-I.
The drug raised IGF-I levels by about 1.7 standard deviations — a big, normal-range boost that shows the treatment worked well without going overboard.
Even when researchers removed blurry or low-quality scans, the link between IGF-I and muscle energy recovery stayed strong — so the finding is reliable.
The muscle energy recovery speed (ViPCr) responded more clearly to IGF-I than another measure (τPCr), meaning ViPCr might be a better way to track how well muscles are making energy.
The drug didn’t make blood sugar or insulin levels better, so its benefits must come from somewhere else — likely directly on muscle energy production.